Skip to main content

Table 1 Patient characteristics

From: A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy

Age (years)

24–84

(median 67)

67)

  

Sex

 Male

75

    

 Female

26

    

Tumor site

 Tongue

5

    

 Gingiva

7

    

 Nasopharynx

14

    

 Oropharynx

34

    

 Hypopharynx

24

    

 Larynx

6

    

 Nasal cavity

1

    

 Paranasal sinuses

9

    

 Unknown

1

    

Histology

 Squamous cell carcinoma

99

    

 Other

2

    

TNM stage

 

N0

N1

N2

N3

T0–1

2

2

8

3

T2

9

3

23

3

T3

10

3

6

1

T4

5

5

18

0

Treatment

Neoadjuvant (+)

41

    

Neoadjuvant (−)

60

    

Concurrent (+)

78

    

Concurrent (−)

23

    

Radiation treatment

 IMRT-4X

46

    

 VMAT-6X

55

    
  1. Abbreviations: IMRT intensity modulated radiotherapy, VMAT volumetric modulated arc therapy
  2. Neoadjuvant therapy: TPF (Docetaxel, Cisplatin, 5-Fluorouracil), TPE (Docetaxel, Cisplatin, Cetuximab), FP (Cisplatin, 5-Fluorouracil), CDDP (Cisplatin), and CBDCA (Carboplatin)
  3. Adjuvant therapy: CDDP (Cisplatin), CBDCA (Carboplatin), and Cet (Cetuximab)